Molecular pathogenesis of splenic and nodal marginal zone lymphoma
Authors:
- 1 March 2017
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 30 (1-2) , 5-12
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 ReceptorsClinical Cancer Research, 2016
- Hepatitis C virus-associated B-cell non-Hodgkin lymphomasHematology-American Society Hematology Education Program, 2014
- A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disordersHaematologica, 2014
- Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?Blood, 2014
- Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic reviewHaematologica, 2013
- Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoireLeukemia, 2012
- Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implicationsLeukemia, 2012
- Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivityBlood, 2011
- Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaHaematologica, 2010
- Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical courseBlood, 2002